{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:43:32Z","timestamp":1793043812527,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022416","name":"Center for Drug Evaluation and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jconrel.2026.115177","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:59:28Z","timestamp":1783954768000},"page":"115177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Mechanistic understanding of LAI suspension intramuscular depot formation: A physicochemical perspective"],"prefix":"10.1016","volume":"397","author":[{"given":"Nilesh","family":"Malavia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanying","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Amaral","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khondoker","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viera","family":"Lukacova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane J.","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115177_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125390","article-title":"Impact of agglomeration on in vitro performance of long-acting injectable suspensions","volume":"673","author":"Malavia","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115177_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124634","article-title":"Novel dissolution methods for drug release testing of long-acting injectables","volume":"664","author":"Malavia","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115177_bb0015","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/pharmaceutics16040552","article-title":"Development of mechanistic in vitro\u2013in vivo extrapolation to support bioequivalence assessment of long-acting Injectables","volume":"16","author":"Amaral Silva","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115177_bb0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1208\/s12248-025-01171-1","article-title":"Mechanistic modeling of intramuscular administration of a long-acting injectable accounting for tissue response at the depot site","volume":"28","author":"Silva","year":"2025","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2026.115177_bb0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2016.03.041","article-title":"The effect of macrophage and angiogenesis inhibition on the drug release and absorption from an intramuscular sustained-release paliperidone palmitate suspension","volume":"230","author":"Darville","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115177_bb0030","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s40265-022-01791-3","article-title":"Cabotegravir extended-release injectable suspension: a review in HIV-1 pre-exposure prophylaxis","volume":"82","author":"Blair","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2026.115177_bb0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2021.06.017","article-title":"Challenges and opportunities in the development of complex generic long-acting injectable drug products","volume":"336","author":"O\u2019Brien","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115177_bb0040","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/bcp.14977","article-title":"Multiparametric magnetic resonance imaging to characterize cabotegravir long-acting formulation depot kinetics in healthy adult volunteers","volume":"88","author":"Jucker","year":"2022","journal-title":"Brit. J. Clin. Pharma"},{"key":"10.1016\/j.jconrel.2026.115177_bb0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2017.10.017","article-title":"Multimodal imaging approach to examine biodistribution kinetics of Cabotegravir (GSK1265744) long acting parenteral formulation in rat","volume":"268","author":"Jucker","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115177_bb0050","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/jps.24014","article-title":"Intramuscular Administration of Paliperidone Palmitate Extended-Release Injectable Microsuspension Induces a subclinical inflammatory reaction modulating the pharmacokinetics in rats","volume":"103","author":"Darville","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115177_bb0055","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jconrel.2021.12.011","article-title":"Effect of particle size on in vivo performances of long-acting injectable drug suspension","volume":"341","author":"Ho","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115177_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2026.126762","article-title":"Impact of macrophages on the dissolution of LAI suspension prodrugs","author":"Malavia","year":"2026","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115177_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114721","article-title":"Insights into development of long-acting injectable suspensions","volume":"392","author":"Malavia","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115177_bb0070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2016.03.041","article-title":"The effect of macrophage and angiogenesis inhibition on the drug release and absorption from an intramuscular sustained-release paliperidone palmitate suspension","volume":"230","author":"Darville","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115177_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120907","article-title":"Effect of polymer source on in vitro drug release from PLGA microspheres","volume":"607","author":"Wan","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115177_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121840","article-title":"In vitro release testing method development for long-acting injectable suspensions","volume":"622","author":"Bao","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115177_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106505","article-title":"Leveraging the use of in vitro and computational methods to support the development of enabling oral drug products: an InPharma commentary","volume":"188","author":"Reppas","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115177_bb0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s41120-025-00122-6","article-title":"Dissolution prediction from images: method and validation of dissoLab platform","volume":"11","author":"Gautreau","year":"2025","journal-title":"AAPS Open"},{"key":"10.1016\/j.jconrel.2026.115177_bb0095","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejpb.2015.09.003","article-title":"Multimodal non-linear optical imaging for the investigation of drug nano\u2212\/microcrystal\u2013cell interactions","volume":"96","author":"Darville","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2026.115177_bb0100","doi-asserted-by":"crossref","DOI":"10.1007\/s10928-022-09835-7","article-title":"Convolution-based approach for modeling the paliperidone extended release and long-acting injectable (LAI) PK of once-, and three-monthly products administration and for optimizing the development of new LAI products","author":"Gomeni","year":"2022","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.jconrel.2026.115177_bb0105","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-023-00799-1","article-title":"Development of drug release model for suspensions in ESCAR (emulator of SubCutaneous absorption and release)","volume":"25","author":"Lou","year":"2023","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2026.115177_bb0110","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2036.2008.03727.x","article-title":"Clinical trial: single- and multiple-dose pharmacokinetics of polyethylene glycol (PEG-3350) in healthy young and elderly subjects","volume":"28","author":"Pelham","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.115177_bb0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/193229680700100103","article-title":"Controlling acute inflammation with fast releasing dexamethasone-PLGA microsphere\/PVA hydrogel composites for implantable devices","volume":"1","author":"Bhardwaj","year":"2007","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.115177_bb0120","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2011.05.067","article-title":"Effect of physical ageing on the performance of dexamethasone loaded PLGA microspheres","volume":"415","author":"Rawat","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115177_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122642","article-title":"Development of in vitro-in vivo correlations for long-acting injectable suspensions","volume":"634","author":"Bao","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115177_bb0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1208\/s12248-022-00695-0","article-title":"Model for long acting Injectables (depot formulation) based on pharmacokinetics and physical chemical properties","volume":"24","author":"Shah","year":"2022","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2026.115177_bb0135","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0016-5085(88)90550-1","article-title":"Osmotic effects of polyethylene glycol","volume":"94","author":"Schiller","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2026.115177_bb0140","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/pharmaceutics12060567","article-title":"Injectable lipid-based depot formulations: where do we stand?","volume":"12","author":"Rahnfeld","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115177_bb0145","series-title":"Pharmaceutical Dosage Forms - Parenteral Medications: Volume 1: Formulation and Packaging","year":"2016"},{"key":"10.1016\/j.jconrel.2026.115177_bb0150","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1248\/cpb.29.817","article-title":"Studies on the absorption of practically water-insoluble drugs following injection. II. Intramuscular absorption from aqueous suspensions in rats","volume":"29","author":"Hirano","year":"1981","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2026.115177_bb0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0022-0248(96)00362-4","article-title":"The crystallization of biological macromolecules from precipitates: evidence for Ostwald ripening","volume":"168","author":"Ng","year":"1996","journal-title":"J. Cryst. Growth"},{"key":"10.1016\/j.jconrel.2026.115177_bb0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijpharm.2010.12.027","article-title":"Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening","volume":"406","author":"Verma","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115177_bb0165","series-title":"Water Science Reviews 3","first-page":"79","article-title":"Water as a plasticizer: physico-chemical aspects of low-moisture polymeric systems","author":"Levine","year":"1988"},{"key":"10.1016\/j.jconrel.2026.115177_bb0170","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1021\/acs.molpharmaceut.1c00519","article-title":"What are the important factors that influence API crystallization in miscible amorphous API\u2013excipient mixtures during long-term storage in the glassy state?","volume":"19","author":"Newman","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115177_bb0175","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1039\/D1MA01079D","article-title":"Coating liposomes with ring-like PEG: the synthesis and stealth effect of cholesterol\u2013PEG\u2013cholesterol","volume":"3","author":"Wang","year":"2022","journal-title":"Mater. Adv."},{"key":"10.1016\/j.jconrel.2026.115177_bb0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1208\/s12248-023-00811-8","article-title":"Long-acting injectable aqueous suspensions\u2014summary from an AAPS workshop","volume":"25","author":"Holm","year":"2023","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2026.115177_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113793","article-title":"Particle size matters: the impact of particle size on properties and performance of long-acting injectable crystalline aqueous suspensions","volume":"383","author":"Liu","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115177_bb0190","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0021-9797(77)90150-3","article-title":"Steric stabilization","volume":"58","author":"Napper","year":"1977","journal-title":"J. Colloid Interface Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926005808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926005808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:31:01Z","timestamp":1787805061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926005808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"alternative-id":["S0168365926005808"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115177","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic understanding of LAI suspension intramuscular depot formation: A physicochemical perspective","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115177"}}